IL-4, IL-6, IL-10, IL-17A and vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy
- 1 Novosibirsk Branch Federal State Institution “Intersectoral Research and Technology Complex” “Eye microsurgery”, Novosibirsk, Russia
- 2 Novosibirsk Branch Federal State Institution “Intersectoral Research and Technology Complex” “Eye microsurgery”, Novosibirsk, Russia
- 3 Novosibirsk Branch Federal State Institution “Intersectoral Research and Technology Complex” “Eye microsurgery”, Novosibirsk, Russia
- 4 Novosibirsk Branch Federal State Institution “Intersectoral Research and Technology Complex” “Eye microsurgery”, Novosibirsk, Russia
- 5 Research Center of Clinical and Experimental Medical, Siberian Branch of Russian Academy of Medical Sciences, Novosibirsk, Russia
- 6 Novosibirsk Branch Federal State Institution “Intersectoral Research and Technology Complex” “Eye microsurgery”, Novosibirsk, Russia; Research Center of Clinical and Experimental Medical, Siberian Branch of Russian Academy of Medical Sciences, Novosibirsk, Russia
Abstract
In current article, results of the determination of the concentrations of vascular endothelial growth factor (VEGF), and some interleukins (IL-4, IL-6, IL-10, IL-17А) in the vitreous of patients with proliferative diabetic retinopathy are presented. We have found that in the mechanism of development of diabetic retinopathy, significant role plays an activation of local inflammation process and vascular proliferation. This is evidenced by a significant increase in the vitreous concentration of IL-4, IL-6, IL-10, IL-17A and vascular endothelial growth factor. Identified correlations between VEGF and IL-17A, between VEGF and IL-4, and between IL-17A and IL-4 show the relationship of inflammation and proliferation processes in the pathogenesis of diabetic retinopathy.
- Balashevich, L.I. (2004) Ocular manifestations of diabetes. Medical Academy of Postgraduate Education, St. Petersburg, 382.
- Libman, E.S., and Shahova, E.V. (2006) Blindness and disability due to pathology of the vision in Russia. Journal of Ophthalmology, 122, 35-37.
- Bhavsar, A.R. (2006) Diabetic retinopathy: The latest in current management. Retina, 26, 71-79. http://dx.doi.org/10.1097/00006982-200607001-00016
- Lim, A., Stewart, J., Chui, T.Y., Lin, M., Ray, K., Lietman, T., Porco, T., Jung, L., Seiff, S. and Lin, S. (2008) Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. Ophthalmic Epidemiology, 15, 402-409. http://dx.doi.org/10.1080/09286580802435179
- Kollias, A.N. and Ulbig, M.W. (2010) Diabetic retinopathy: Early diagnosis and effective treatment. Deutsches Ärzteblatt international, 107, 75-83.
- Sadaka, A. and Giuliari, G.P. (2012) Proliferative vitreoretinopathy: Current and emerging treatments. Journal of Clinical Ophthalmology, 6, 1325-1333.
- Chernykh, V.V., Lysikov, A.G., Obukhova, O.O., Gorbenko, O.M., Shvayuk, A.P. and Trunov, A.N. (2011) Features of local immunoinflammatory process at nonproliferative diabetic retinopathy. Bulletin of the Novosibirsk State University, 9, 164-168.
- Khodjaev, N.S., Chernykh, V.V., Romenskaya, I.V., Kuntysheva, K.E. and Trunov, A.N. (2011) Effect of laser coagulation retina on clinical-laboratory parameters in patients diabetic macular edema. Bulletin of the Novosibirsk State University, 9, 48-53.
- Kowluru, R.A., Zhong, Q. and Kanwar, M. (2010) Metabolic memory and diabetic retinopathy: Role of inflammatory mediators in retinal pericytes. Experimental Eye Research, 90, 617-623. http://dx.doi.org/10.1016/j.exer.2010.02.006
- Rasier, R., Gormus, U., Artunay, O., Yuzbasioglu, E., Oncel, M. and Bahcecioglu, H. (2010) Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment. Current Eye Research, 35, 505-509. http://dx.doi.org/10.3109/02713681003597248
- Symeonidis, C., Papakonstantinou, E., Androudi, S., Rotsos, T., Diza, E., Brazitikos, P., Karakiulakis, G. and Dimitrakos, S.A. (2011) Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy. Cytokine, 54, 212-217. http://dx.doi.org/10.1016/j.cyto.2011.02.001
- Slepova, O.S., Neroev, V.V., Ilyukhin, P.A. and Sarygina, O.I. (2012) Immunological control of in the surgical treatment of patients with proliferative diabetic retinopathy with preliminary introduction to the vitreous Lucentis. Russian Ophthalmological Journal, 1, 69-74.